AIM ImmunoTech EPS Basic from Accounting Change (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.22 -0.10 (-7.40%) USD | NYAM | Dec 30, 13:11

View EPS Basic from Accounting Change (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	--
Electromed, Inc.	--
Armata Pharmaceuticals, Inc.	--